Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Enalapril Maleate prices in Germany, the highest-cost reporting region, rose 7.0% in H1 2026, climbing from USD 54.8/KG in Q1 to USD 58.6/KG by Q2 as recovering hypertension, chronic heart failure, and diabetic nephropathy formulation procurement and firmer enalaprilat synthesis intermediate costs reversed the H2 2025 market softening. Globally, the average rose from USD 37.96/KG in Q1 to USD 40.62/KG in Q2, a 7.0% gain. For H2 2026, a global average of USD 39.8-44.7/KG is expected, with continued firming on Middle East supply disruptions and growing antihypertensive, heart failure, and diabetic nephropathy sector demand globally.
Enalapril Maleate is the maleate salt of enalapril, an ethyl ester prodrug of the active diacid enalaprilat, produced by multi-step synthesis from L-alanine and L-proline amino acid building blocks through peptide-bond condensation, introduction of the N-carboxymethyl dipeptide moiety, ethyl esterification to achieve oral bioavailability, and maleic acid salt formation to yield the crystalline active pharmaceutical ingredient. Following oral absorption, hepatic esterases cleave the ethyl ester to release enalaprilat, which inhibits angiotensin-converting enzyme, preventing the conversion of angiotensin I to the potent vasoconstrictor angiotensin II and reducing aldosterone secretion to produce vasodilation and lower cardiac preload and afterload. The largest pull comes from first-line hypertension treatment, where enalapril tablets serve as widely prescribed and cost-effective generic options in essential medicine programmes globally. Chronic heart failure mortality reduction, asymptomatic left ventricular dysfunction prevention, and diabetic nephropathy proteinuria management add further significant demand. L-alanine and L-proline synthesis intermediate costs, hypertension and heart failure prescribing volumes and essential medicine programme procurement, and regional API synthesis capacity all feed into the price.
The balance of supply and demand for Enalapril Maleate through H2 2026 leans moderately firm. Synthesis intermediate costs firmed from Middle East chemical supply disruptions. Hypertension treatment, heart failure management, and diabetic nephropathy demand are growing with expanding cardiovascular treatment access and ageing global demographics.
The main upside risk is synthesis intermediate cost increases alongside accelerating heart failure and hypertension access programme procurement. The main downside risk is Chinese and Indian API surplus and continued generic competition maintaining price pressure below the forecast range.
| Region | Price Forecast (USD/KG) | Key Driver |
| Global Average | 39.8 - 44.7 | Synthesis cost firming and hypertension/heart failure demand |
| United States | 43.1 - 48.0 | Steady hypertension and heart failure demand holds firm |
| China | 30.0 - 34.9 | Large API capacity keeps it the most affordable |
| Germany | 54.5 - 59.4 | High synthesis and energy costs keep it the most expensive |
| India | 41.8 - 46.7 | Growing antihypertensive and export demand holds a firm middle |
US Enalapril Maleate prices averaged USD 47.0/KG in Q2 2026, up 7.1% from USD 43.9/KG in Q1 2026. Firmer synthesis intermediate costs and recovering hypertension and heart failure formulation procurement drove consistent buying through the quarter.
Why did the price of Enalapril Maleate change in Q2 2026 in the United States?
Firmer L-alanine and enalaprilat synthesis intermediate costs raised the API production floor. Hypertension tablet, heart failure, and diabetic nephropathy formulation procurement lifted buying. Essential medicine programme replenishment provided additional support near USD 47.0/KG.
Chinese Enalapril Maleate prices averaged USD 32.5/KG in Q2 2026, up 6.9% from USD 30.4/KG in Q1 2026, the lowest among the tracked markets. Spring hypertension and heart failure export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.
Why did the price of Enalapril Maleate change in Q2 2026 in China?
Spring hypertension and heart failure export and domestic procurement lifted buying. Firmer domestic synthesis intermediate costs raised the production floor. Large domestic API capacity kept China the most affordable source near USD 32.5/KG.
German Enalapril Maleate prices averaged USD 58.6/KG in Q2 2026, up 7.0% from USD 54.8/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European production economics. Recovering hypertension and heart failure demand maintained buying.
Why did the price of Enalapril Maleate change in Q2 2026 in Germany?
Higher synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to amino acid synthesis chains. Recovering hypertension, heart failure, and diabetic nephropathy procurement maintained buying near USD 58.6/KG.
Indian Enalapril Maleate prices averaged USD 45.4/KG in Q2 2026, up 7.1% from USD 42.4/KG in Q1 2026. Growing hypertension and heart failure export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.
Why did the price of Enalapril Maleate change in Q2 2026 in India?
Growing hypertension and heart failure export and domestic procurement lifted buying. Firmer synthesis import costs raised the production floor. Essential medicine programme and diabetic nephropathy export demand provided additional support near USD 45.4/KG.
US prices averaged USD 43.9/KG in Q1 2026, recovering about 4.0% from the Q4 2025 trough. Recovering hypertension and heart failure demand and firming synthesis costs held the market near USD 43.9/KG.
Why did the price of Enalapril Maleate change in Q1 2026 in the United States?
Recovering hypertension and heart failure formulation procurement maintained buying. Firming synthesis intermediate costs raised the production floor. The market recovered to USD 43.9/KG from the H2 2025 softening trough.
Chinese prices averaged USD 30.4/KG in Q1 2026, recovering about 4.1% from Q4 2025. Post-Lunar New Year hypertension and heart failure restocking and firmer synthesis costs held the market near USD 30.4/KG.
Why did the price of Enalapril Maleate change in Q1 2026 in China?
Post-Lunar New Year hypertension and heart failure restocking lifted buying. Firming domestic synthesis intermediate costs raised the floor. The market recovered to USD 30.4/KG from the H2 2025 softening trough.
German prices averaged USD 54.8/KG in Q1 2026, recovering about 4.1% from Q4 2025. Recovering hypertension and heart failure demand and firming synthesis and energy costs held the market near USD 54.8/KG.
Why did the price of Enalapril Maleate change in Q1 2026 in Germany?
Recovering hypertension, heart failure, and diabetic nephropathy procurement maintained buying. Firming synthesis and energy costs raised the production floor. The market recovered to USD 54.8/KG from the H2 2025 trough.
Indian prices averaged USD 42.4/KG in Q1 2026, recovering about 3.9% from Q4 2025. Growing hypertension and heart failure demand and firmer synthesis import costs held the market near USD 42.4/KG.
Why did the price of Enalapril Maleate change in Q1 2026 in India?
Growing hypertension and heart failure procurement maintained buying. Firming synthesis import costs raised the production floor. The market recovered to USD 42.4/KG from the H2 2025 softening trough.
Global Enalapril Maleate prices declined through H2 2025 on synthesis cost softening before recovering firmly through Q1 and Q2 2026. The average fell from USD 38.0/KG in Q2 2025 to USD 37.24/KG in Q3 and USD 36.50/KG in Q4, then recovered to USD 37.96/KG in Q1 2026 and USD 40.62/KG in Q2 2026, a net gain of about 6.9% over the window. Synthesis intermediate cost cycles and hypertension, heart failure, and diabetic nephropathy procurement drove the H2 2025 softening and H1 2026 recovery.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 40.62 | +7.0% | ↑ Rising |
| Q1 2026 | 37.96 | +4.0% | ↑ Rising |
| Q4 2025 | 36.50 | -2.0% | ↓ Falling |
| Q3 2025 | 37.24 | -2.0% | ↓ Falling |
| Q2 2025 | 38.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Enalapril Maleate prices declined through 2025 on synthesis cost softening and stable hypertension prescription volumes. The global average opened near USD 38.8/KG in Q1 2025 and closed at USD 36.50/KG in Q4, a full-year decline of about 5.9%. Synthesis intermediate cost softening and steady antihypertensive demand maintained conditions before the H1 2026 recovery.
US prices fell from about USD 43.1/KG in Q1 2025 to USD 42.2/KG by Q4, a decline of 2.1%. Soft synthesis costs maintained downward pressure through the year.
Chinese prices fell from roughly USD 29.8/KG in Q1 2025 to USD 29.2/KG by Q4, a decline of 2.0%. Large domestic API capacity and soft synthesis costs maintained the lowest level.
German prices fell from about USD 53.6/KG in Q1 2025 to USD 52.7/KG by Q4, a decline of 1.7%. Soft synthesis costs maintained moderate downward pressure through the year.
Indian prices fell from roughly USD 41.6/KG in Q1 2025 to USD 40.8/KG by Q4, a decline of 1.9%. Soft synthesis import costs maintained downward pressure through the year.
Expert Market Research: Your Source for Real-Time Enalapril Maleate Price Intelligence
Expert Market Research tracks Enalapril Maleate prices continuously across every major producing and consuming region. The team traces causation through L-alanine and enalaprilat synthesis intermediate economics, hypertension and heart failure prescription cycles, and regional API production capacity. Contact Expert Market Research today for Enalapril Maleate pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
First-line hypertension treatment as a widely prescribed and cost-effective generic option in essential medicine programmes globally takes the largest share. Chronic heart failure management reducing mortality and hospitalisation, asymptomatic left ventricular dysfunction prevention of progression to overt failure, and diabetic nephropathy proteinuria reduction also consume significant volumes globally.
The Q2 2026 average was USD 47.0/KG in the United States, USD 32.5/KG in China, USD 58.6/KG in Germany, and USD 45.4/KG in India. Germany remains the highest-priced market.
The global average rose from USD 37.96/KG in Q1 to about USD 40.62/KG in Q2, a gain of around 7.0%. Recovering hypertension and heart failure demand and firmer synthesis intermediate costs drove the H1 recovery from the H2 2025 softening trough.
L-alanine and enalaprilat synthesis intermediate cost softening reduced the API production floor. Stable antihypertensive prescription volumes and generic price competition maintained downward pressure before the H1 2026 recovery.
The global average is expected in the USD 39.8 to 44.7/KG range for H2 2026, with continued firming as synthesis costs stay elevated and hypertension, heart failure, and diabetic nephropathy demand grows globally.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on antihypertensive demand, and China prices lowest on domestic API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to L-alanine and enalaprilat synthesis intermediate costs, hypertension and heart failure prescribing cycles, and cardiovascular treatment access expansion. Amino acid precursor prices and heart failure hospitalisation data are key signals.
China and India hold the largest enalapril maleate API synthesis capacity. Any synthesis intermediate cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time hypertension and heart failure formulation contracts around synthesis cost cycles, build cover when intermediate signals tighten, and monitor cardiovascular prescribing volumes as the primary demand signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.